- The trend backdrop is active with a 3-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
DOCS
LSE
Week ended 07 Aug 2026
Weekly Investor Report
Dr. Martens plc · Consumer Cyclical · Footwear & Accessories
Latest close
0.84 GBP
8.0%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 20.9% above the Trend Line and sits at 60.5% of its 52-week range. The latest completed week returned 8.0%, after a 16.9% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 53/100.
Setup score
52
out of 100
Latest Close
0.84 GBP
7 Aug 2026
1W Return
8.0%
latest completed week
4W Return
16.9%
short-term follow-through
12W Return
34.2%
quarterly tape
Trend Breadth
36.5%
19 of 52 weeks active
Volume Ratio
1.0x
vs 13-week average
- Next-week expectancy is negative at 42.68% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
8.0%
Latest completed week; four-week move 16.9%.
Indicator stack
30/70
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 42.68%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
53/100
11 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 20.9% above the Trend Line and sits at 60.5% of its 52-week range. The latest completed week returned 8.0%, after a 16.9% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.5112-week average 0.33
12-week confirmation
Trend active3/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership1/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.51Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 16.9% over four weeks, 34.2% over 12 weeks, and 12.2% over one year. The current trend has remained active for 3 consecutive weeks.
Performance by holding period
Active trend streak3 weeks
Active weeks in one year19
Trend breadth36.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.04Latest activity-pressure read.
Pressure change15.0%Four-week change in activity pressure.
Leadership1.96Latest relative-leadership reading.
RS change118.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 88%
Model confidence 82%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength67/100Blend of value, momentum, and quality. Underlying universe rank 34; rank 1 is best.
Value62/100Relative valuation strength. Underlying universe rank 39; rank 1 is best.
Quality63/100Profitability and accounting quality. Underlying universe rank 38; rank 1 is best.
Momentum63/100Medium-term price momentum. Underlying universe rank 38; rank 1 is best.
Growth63/100Revenue and earnings growth. Underlying universe rank 38; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework91/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 0.3x Price divided by trailing earnings.
- Price / sales
- 0.0x Market value relative to trailing revenue.
- EV / EBITDA
- 1.7x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 59.1% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 66.2% Gross profit retained from each unit of revenue.
- Operating margin
- 7.9% Operating profit retained from revenue.
- Free-cash-flow margin
- 17.1% Free cash flow generated from revenue.
- Return on invested capital
- 7.9% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- -2.9% Latest one-year revenue growth.
- EPS growth
- 432.9% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- -26.4% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 7/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- 83.7% Net share repurchases relative to market value.
- Shareholder yield
- 83.7% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 1.7x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment53/100
Weighted news tone is neutral across 11 relevant articles.
2 positive · 7 neutral · 2 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-16.0%Distance below the 52-week high.
13-week volatility5.0%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher15 of 2610 weeks finished lower.
Best week+11.7%Week of 22 May.
Worst week-8.3%Week of 24 Apr.
Latest week+8.0%Week of 7 Aug.
Shape of recent returns
Strong gains7
Modest gains8
Flat weeks1
Modest losses5
Sharp losses5
Recent vol5.0%13-week weekly-return volatility.
Base vol5.6%52-week weekly-return volatility.
Up/down split25/25Count of positive and negative weeks in the 52-week window.
Average skew4.5% / -3.7%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorGB Consumer Cyclical
4-week rank8 / 100
Group average5.3%
Trend breadth48.0%
Trend48.0%active weekly trend signals
MD74.0%positive activity pressure
RS43.0%positive relative leadership
Four-week leaders
IndustryGB Footwear & Accessories
4-week rank2 / 2
Group average22.8%
Trend breadth100.0%
Trend100.0%active weekly trend signals
MD100.0%positive activity pressure
RS100.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape45/100
Trend, activity pressure, participation, and risk combine to a 45/100 tape read.
Indicator analysis47/100Latest 12-week confirmation: trend 3/12, activity pressure 12/12, relative leadership 1/12.
Activity pressure 0.51; No reversal markers Next-Week ExpectancyNegative 42.68%Next-week expectancy is negative with a 42.68% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors63/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 1 SVQF91/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 25.0 of 260 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment53/100Weighted news tone is neutral across 11 relevant articles.
DOCS Q2 Deep Dive: AI Product Adoption Fuels Revenue Growth, Margins Face Investment Pressures Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 0.84 GBP | 8.0% | 0.69 GBP | 0.77 GBP | 1.04 | 1.96 | 5.1M | On |
| 31 Jul 2026 | 0.77 GBP | 4.9% | 0.69 GBP | 0.77 GBP | 1.08 | -5.44 | 3.8M | On |
| 24 Jul 2026 | 0.74 GBP | -2.8% | 0.69 GBP | 0.77 GBP | 1.01 | -9.01 | 2.6M | On |
| 17 Jul 2026 | 0.76 GBP | 6.2% | 0.69 GBP | 0.78 GBP | 1.04 | -5.71 | 7.7M | Off |
| 10 Jul 2026 | 0.71 GBP | 0.0% | 0.69 GBP | 0.78 GBP | 0.91 | -10.62 | 10.8M | Off |
| 3 Jul 2026 | 0.71 GBP | -0.3% | 0.69 GBP | 0.78 GBP | 0.79 | -12.52 | 1.6M | Off |
| 26 Jun 2026 | 0.72 GBP | 2.4% | 0.69 GBP | 0.79 GBP | 0.82 | -11.24 | 1.8M | Off |
| 19 Jun 2026 | 0.70 GBP | -4.5% | 0.69 GBP | 0.79 GBP | 0.94 | -12.50 | 3.3M | Off |
| 12 Jun 2026 | 0.73 GBP | 3.2% | 0.69 GBP | 0.79 GBP | 1.03 | -9.66 | 2.1M | Off |
| 5 Jun 2026 | 0.71 GBP | -4.1% | 0.70 GBP | 0.79 GBP | 0.83 | -11.86 | 4.9M | Off |
| 29 May 2026 | 0.74 GBP | 6.3% | 0.70 GBP | 0.80 GBP | 0.68 | -8.99 | 11.4M | Off |
| 22 May 2026 | 0.70 GBP | 11.7% | 0.71 GBP | 0.80 GBP | 0.26 | -14.75 | 9.8M | Off |
| 15 May 2026 | 0.62 GBP | -4.2% | 0.71 GBP | 0.81 GBP | -0.08 | -21.56 | 5.0M | Off |
| 8 May 2026 | 0.65 GBP | 4.8% | 0.72 GBP | 0.81 GBP | -0.03 | -18.60 | 4.2M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.